These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8576843)

  • 21. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.
    Barré J; Chamouard JM; Houin G; Tillement JP
    Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
    Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
    Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the free fraction and relative free fraction of drugs strongly bound to plasma proteins.
    Schuhmacher J; Bühner K; Witt-Laido A
    J Pharm Sci; 2000 Aug; 89(8):1008-21. PubMed ID: 10906724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment of plasma samples by a novel hollow fiber centrifugal ultrafiltration technique for the determination of plasma protein binding of three coumarins using acetone as protein binding releasing agent.
    Li J; Shi Q; Jiang Y; Liu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():114-23. PubMed ID: 26276065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
    Zhang F; Xue J; Shao J; Jia L
    Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide.
    Rohatagi S; Luo Y; Shen L; Guo Z; Schemm C; Huang Y; Chen K; David M; Nave R; King SP
    Am J Ther; 2005; 12(3):201-9. PubMed ID: 15891262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein binding of five platinum compounds. Comparison of two ultrafiltration systems.
    van der Vijgh WJ; Klein I
    Cancer Chemother Pharmacol; 1986; 18(2):129-32. PubMed ID: 3791557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein binding of enprofylline.
    Tegnér K; Borgå O; Svensson I
    Eur J Clin Pharmacol; 1983; 25(5):703-8. PubMed ID: 6420163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The separation of free and bound vitamin B12.
    Adams JF; McEwan FC
    Br J Haematol; 1974 Apr; 26(4):581-92. PubMed ID: 4858622
    [No Abstract]   [Full Text] [Related]  

  • 33. Solutizers as an adjunct to artificial organ treatment for bound chemicals.
    Dorson WJ; Pizziconi VB; Sizto CN; Radnoti RP; Zarembinski CJ; Aniuk LM
    Trans Am Soc Artif Intern Organs; 1980; 26():116-9. PubMed ID: 7245465
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials.
    Reimerová P; Stariat J; Bavlovič Piskáčková H; Jansová H; Roh J; Kalinowski DS; Macháček M; Šimůnek T; Richardson DR; Štěrbová-Kovaříková P
    Anal Bioanal Chem; 2019 Apr; 411(11):2383-2394. PubMed ID: 30820631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of compound binding to plasma proteins.
    Dow N
    Curr Protoc Pharmacol; 2006 Oct; Chapter 7():Unit7.5. PubMed ID: 22294178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rat in vitro plasma-binding percentage determination of sinomenine hydrochloride by using microdialysis method and ultrafiltration].
    Zhang Y; Zhou L
    Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(19):2616-9. PubMed ID: 21174777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the serum protein binding of oxycodone and morphine using ultrafiltration.
    Leow KP; Wright AW; Cramond T; Smith MT
    Ther Drug Monit; 1993 Oct; 15(5):440-7. PubMed ID: 8249052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
    Skoczen SL; Stern ST
    Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.